This release includes the submission of major changes in accordance with Art. 41 para. 2 MPLO (establishment licences), as well as the viewing of specialist data for complementary medicines in the notification procedure (Chapter 7 KPTPO; basic company dossier, master dossier and medicines (single notifications)) by the marketing authorisation holders.
Excerpt from the official page. The original is authoritative.